Related by context. Frequent words. (Click for all words.) 59 multicenter randomized double 57 SPIRIT III 57 Phase 1b clinical 56 multicentre 55 prospective randomized 55 multicenter 54 placebo controlled 54 Phase 1b 54 randomized controlled clinical 53 blind randomized placebo 53 Phase 2a clinical 53 blind randomized 53 blinded placebo controlled 53 randomized controlled 53 Coronary Stent 53 Phase IIa clinical 52 CYPHER R Stent 52 TAXUS 52 Phase Ib 52 carotid stenting 52 non inferiority 52 REALIZE 52 randomized placebo controlled 51 ASCOT 51 Phase 2b study 51 phase IIb 51 phase 2a 51 randomized clinical 51 Phase III pivotal 51 telmisartan 51 CYPHER ® Stent 51 Phase IIa trial 51 bosentan 50 ACTEMRA 50 Phase 2b 50 randomized #:# 50 blind placebo controlled 50 Phase III 50 dose escalation trial 50 ZYBRESTAT 49 Phase 2b clinical 49 rosuvastatin 49 Endeavor stent 49 double blind placebo 49 randomized 49 Investigational Device Exemption IDE 49 randomized Phase 49 pivotal Phase III 49 DURATION 49 TAXUS R 49 label dose escalation 49 Phase 2a trial 49 randomized double 49 Phase IIb 48 Phase IIb clinical 48 multicenter study 48 drug eluting stent 48 tolerability 48 substudy 48 COPAXONE R 48 Taxotere ® 48 Phase 2b trial 48 rivaroxaban 48 Randomized 48 evaluable 48 Secondary endpoints 48 everolimus 48 Phase IIa 47 pharmacodynamics 47 lacosamide 47 efficacy endpoints 47 dose escalation 47 MitraClip 47 LEVADEX 47 dose escalation study 47 Phase 2a 47 SENTINEL 47 Taxotere R 47 Bronchitol 47 Completes Enrollment 46 PF # [001] 46 ISIS # 46 VALOR 46 ISENTRESS 46 Phase III clinical 46 Cotara 46 placebo controlled trials 46 events AEs 46 primary endpoints 46 single ascending dose 46 Phase IIb trial 46 efficacy 46 XGEVA 46 safety tolerability pharmacokinetics 46 pharmacokinetic 46 Phase III Trial 46 primary endpoint 46 ticagrelor 45 TMC# [001] 45 secondary endpoint 45 XIAFLEX